Filter
2896
Filtered Results: 2896
Text search:
point-of-care
technologies
Featured
Recommendations
287
New Publications
763
Language
Document type
No document type
1521
Studies & Reports
531
Guidelines
401
Manuals
177
Strategic & Response Plan
162
Training Material
45
Fact sheets
34
Situation Updates
11
Resource Platforms
7
Brochures
3
Infographics
3
Online Courses
1
Countries / Regions
Global
151
Kenya
116
India
92
Western and Central Europe
60
Ethiopia
54
Uganda
52
Nepal
49
Africa
48
Latin America and the Carribbean
45
Rwanda
43
South Africa
42
Zambia
40
Sierra Leone
39
Nigeria
39
Myanmar / Burma
39
Malawi
37
Liberia
35
Ghana
35
Tanzania
33
Bangladesh
32
Namibia
26
Ukraine
25
South–East Asia Region
24
Congo, Democratic Republic of
23
Philippines
22
Asia
21
Eastern Europe
20
Senegal
19
Guinea
17
Syria
17
West and Central Africa
17
Lesotho
16
Cambodia
15
East and Southern Africa
15
Mozambique
14
Eastern Europe and Central Asia
14
Zimbabwe
13
South Sudan
10
Haiti
9
Brazil
9
Botswana
9
Yemen
9
Middle East and North Africa
9
Western Pacific Region
9
Burkina Faso
8
Cameroon
8
Eswatini/ Swaziland
8
Russia
8
Mali
7
USA
7
Thailand
7
Indonesia
7
Colombia
7
Germany
6
Côte d’Ivoire / Ivory Coast
5
Somalia
5
Sudan
5
Madagascar
5
Laos
5
Pakistan
4
Iraq
4
Afghanistan
4
China
4
Benin
4
Argentina
4
Peru
4
Venezuela
4
Southern Africa
4
Vietnam
4
North America
4
Chad
3
Angola
3
Chile
3
Tajikistan
3
Moldova
3
Niger
2
Togo
2
Jordan
2
Papua New Guinea
2
North Macedonia
2
Sri Lanka
2
Paraguay
2
Timor Leste/ East Timor
2
Bulgaria
2
France
2
Lebanon
1
Malaysia
1
Singapore
1
Central African Republic
1
Serbia
1
Hungary
1
Croatia
1
Ecuador
1
El Salvador
1
Bolivia
1
Bhutan
1
Poland
1
Albania
1
Armenia
1
Congo-Brazzaville
1
Romania
1
Slovakia
1
Uzbekistan
1
Georgia
1
Gabon
1
Turkmenistan
1
Jamaica
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
979
Public Health
206
Clinical Guidelines
201
Key Resources
171
Women & Child Health
127
Pharmacy & Technologies
73
Capacity Building
40
Annual Report MEDBOX
1
Toolboxes
COVID-19
258
HIV
228
TB
177
Planetary Health
153
Disability
142
Mental Health
127
Caregiver
104
AMR
102
Rapid Response
94
Global Health Education
77
Pharmacy
75
Conflict
64
NTDs
58
Ebola
56
NCDs
52
Refugee
36
Natural Hazards
35
Health Financing Toolbox
31
Specific Hazards
27
Social Ethics
23
Polio
11
Zika
11
Cholera
8
Typhoon
1
Health Financing
1
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment ... the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The 2021 edition of the report has been produced in a new and more web-centric format. This is designed to make the content available in smaller (more “bite-sized”) chunks that are easier to read, digest, navigate and use. There is a short and slim report PDF with 30 pages of main content plus six short annexes. This is accompanied by expanded and more detailed digital content on web pages. The total amount of content remains similar to that of previous years.
Available in English, French, Arabic and Chinese
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty ... their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines faster over the three-year estimated life of an ITN; therefore, the added impact of
pyrethroid-PBO ITNs over that of pyrethroid-only LLINs may decline over time. The evidence comes from two sites in
eastern Africa with pyrethroid resistance and not from other geographies where transmission levels and vector characteristics
may vary. PBO acts by inhibiting certain metabolic enzymes, primarily oxidases, and so are likely to provide greater protection
than pyrethroid-only LLINs where mosquitoes display mono-oxygenase-based insecticide resistance mechanisms.
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, ...
Further Analysis of the 2000, 2005, and 2011 Demographic and Health Surveys. DHS Further Analysis Reports No. 83
A non-exhaustive reference list of organizations working with and for persons with disabilities world-wide.
This brief gives an overview of disability rights in the Sub-Saharan region, with focus on Sida partner countries; DRC, Ethiopia, Kenya, Liberia, Mali, Mozambique, Rwanda, Somalia, Sudan and South Sudan, Tanzania, Uganda, Zambia and Zimbabwe
Accessed on 21.05.2020
Considering a hotline? This set of tools will help you assess, set up and manage different types of channels to communicate with communities during humanitarian crises.
Contact tracing is a key component of the COVID-19 response, particularly as societies begin to lift non-pharmaceutical interventions. However, it is a time-consuming and resource-intensive effort that depends on a trained and motivated workforce. E...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and di...
World Health Organization Department of Reproductive Health and Research
Brocher Foundation, Hermance, Geneva, Switzerland, 27–29 April 2016
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa...
Trachoma is one of the 17 WHO-defined Neglected Tropical Diseases
(NTDs) that affect over 1 billion of the world’s poorest and most
marginalized people. It is caused by the bacterium chlamydia t...
The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for
surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing
event-based surveillance (EBS) using a multisectoral, One Health approach. To ...
Rebuilding Liberia’s health system is crucial for improving the country’s overall health outcomes. This annual report highlights key achievements, challenges,and lessons learned in implementing programmes of technical cooperation with the Gov...
The World health statistics report is the annual compilation of health and health-related indicators which has been published by the World Health Organization (WHO) since 2005. The 2023 edition reviews more than 50 health-related indicators from the...
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment ... the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
In many countries neonatal tetanus is responsible for half of all neonatal deaths due to vaccine-preventable diseases and for almost 14% of al¡ infant deaths. It is estimated that in the 1970s more...
WSTP-I is the second part of the WHO wheelchair service training package series and focusses more on addressing the needs of people who have severe difficulties in walking and moving around and als...
This is the first version of the INEE technical guideline to support education during the Covid-19 pandemic. It is a living document that will be regularly updated to meet the learning and well-being needs ... children, adolescents, youth, teachers, caregivers and other education personnel affected by Covid-19.
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl...
